EN
登录

丹纳赫将收购马西莫公司埃克萨资本收购StaffReady

Danaher To Acquire Masimo Corporation | Exa Capital Acquires StaffReady

Healthcare IT Today 等信源发布 2026-03-10 21:12

可切换为仅中文


Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past

查看今天完成并购交易的精选公司,并务必查看过去的完整列表

healthcare IT M&A

医疗IT并购

.

Danaher To Acquire Masimo Corporation

丹纳赫将收购迈心诺公司

Danaher Corporation

丹纳赫公司

, a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire

,一家全球科技和创新企业,今天宣布已达成最终协议收购

Masimo Corporation

马西莫公司

, a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for

,一家领先的特殊诊断供应商,主要在急性护理环境中提供脉搏血氧仪和其他患者监测解决方案。根据协议条款,丹纳赫将收购马西莫所有已发行的普通股,价格为

$180

180美元

per share in cash, or a total enterprise value of approximately

每股现金,或约总计企业价值

$9.9 billion

99亿美元

including assumed indebtedness and net of acquired cash. This represents a transaction multiple of approximately 18x estimated 2027 EBITDA, or 15x 2027 estimated EBITDA, including the full benefit of expected annual synergies.

包括假设的债务和扣除收购所得现金。这相当于约18倍的2027年预估EBITDA,或15倍的2027年预估EBITDA,包括预期年度协同效应的全部收益。

Rainer M. Blair

赖纳·M·布莱尔

, President and Chief Executive Officer at Danaher, said, “We are excited to welcome the Masimo team to Danaher. We’ve followed this innovative company for many years and see it as an exceptional strategic fit for Danaher. Masimo is a leader in pulse oximetry and other patient monitoring solutions, which, combined with its trusted brand and differentiated technology, will greatly strengthen our diagnostics franchise.

丹纳赫公司总裁兼首席执行官表示:“我们非常高兴欢迎Masimo团队加入丹纳赫。多年来,我们一直关注这家创新型公司,认为它与丹纳赫具有卓越的战略契合性。Masimo是脉搏血氧仪及其他患者监测解决方案的领导者,结合其值得信赖的品牌和差异化技术,将极大增强我们的诊断业务。”

With the Danaher Business System and our global scale, we see opportunities to expand Masimo’s reach and continue improving outcomes for patients, particularly those in acute care settings.”.

通过丹纳赫商业系统和我们的全球规模,我们看到了扩大Masimo覆盖范围的机会,并继续改善患者尤其是急症护理环境中的患者的治疗效果。

Julie Sawyer Montgomery

朱莉·索耶·蒙哥马利

, Executive Vice President for Diagnostics at Danaher, said, “Masimo’s advanced sensor technology and AI-enabled monitoring bring powerful new capabilities to our diagnostics portfolio. Integrating these strengths into Danaher will create meaningful opportunities to innovate for clinicians and improve decision-making in critical settings.”.

丹纳赫诊断部门执行副总裁表示:“Masimo 的先进传感技术和人工智能监测功能为我们的诊断产品组合带来了强大的新能力。将这些优势整合到丹纳赫中,将为临床医生创造有意义的创新机会,并改善关键环境中的决策。”

Upon completion of the transaction, Masimo will be a standalone operating company within Danaher’s Diagnostics segment, along with Radiometer, Leica Biosystems, Cepheid, and Beckman Coulter Diagnostics. Masimo is expected to be accretive to adjusted diluted net earnings per common share by

交易完成后,Masimo将成为丹纳赫诊断部门旗下的独立运营公司,与Radiometer、Leica Biosystems、Cepheid和Beckman Coulter Diagnostics并列。Masimo预计将会对调整后的稀释每股普通股净收益产生增值作用。

$0.15

0.15美元

to

$0.20

0.20美元

in the first full year and approximately

在第一整年和大约

$0.70

0.70美元

in the fifth full year following completion of the acquisition. Masimo is expected to deliver high-single-digit core revenue growth over the long-term, accelerating Danaher’s Diagnostics segment core revenue growth profile.

在完成收购后的第五个完整年度。Masimo有望实现长期高个位数的核心收入增长,从而加速丹纳赫诊断部门的核心收入增长。

Under Danaher’s ownership, Masimo is expected to generate EBITDA of more than

在丹纳赫公司的所有权下,Masimo预计将会产生超过

$530 million

5.3亿美元

in 2027. Additionally, Danaher expects to realize more than

在2027年。此外,丹纳赫预计将会实现超过

$125 million

1.25亿美元

of annual cost synergies and more than

每年协同成本超过

$50 million

5000万美元

of annual revenue synergies by the fifth full year…

第五个完整年度的收入协同效应……

Full release here

完整发布在这里

, originally announced February 17th, 2026.

,最初宣布于2026年2月17日。

Exa Capital Acquires StaffReady

Exa Capital 收购 StaffReady

Exa Capital

Exa资本

, a strategic long-term operator that buys and holds enterprise software companies forever, is proud to announce the acquisition of

,一家战略性长期运营商,收购并永久持有企业软件公司,自豪地宣布收购了

StaffReady

员工就绪

, a leading SaaS platform for clinical workforce management in healthcare.

,一个领先的医疗保健临床劳动力管理SaaS平台。

Founded in 1995 and cloud-native since 2002, StaffReady delivers a mission-critical platform purpose-built for managing clinical workforces across multiple healthcare industries. The StaffReady platform supports hospital ancillary departments such as laboratories, pharmacies, PT, rehab, and support services, as well as standalone bioscience, pharmaceutical, and commercial lab test design corporations.

成立于1995年,并自2002年起实现云原生,StaffReady提供了一个专为跨多个医疗行业管理临床劳动力而构建的关键任务平台。StaffReady平台支持医院的辅助部门,如实验室、药房、物理治疗、康复和支持服务,同时也服务于独立的生物科学、制药和商业实验室测试设计公司。

The platform enables healthcare organizations to streamline compliance, staff scheduling, inspection preparation, and workforce readiness, ensuring the right people are in the right place at the right time..

该平台使医疗保健组织能够简化合规性、员工排班、检查准备和劳动力准备,确保合适的人在合适的时间出现在合适的地点。

The acquisition reinforces Exa Capital’s presence in healthcare technology and expands its portfolio into the space of clinical workforce, where efficiency, compliance, and patient safety intersect.

此次收购加强了Exa Capital在医疗技术领域的地位,并将其投资组合扩展到临床劳动力领域,这一领域是效率、合规性和患者安全的交汇点。

“StaffReady has built a platform that sits at the core of clinical workforce operations,” said Mike Knebel, Portfolio Manager at Exa Capital. “Their deep understanding of compliance, scheduling, and inspection readiness reflects years of thoughtful execution. We’re looking forward to working closely with the team to strengthen operations, support product innovation, and help scale the business responsibly over the long term.”.

“StaffReady打造了一个处于临床劳动力运营核心的平台,”Exa Capital的投资组合经理迈克·内贝尔表示。“他们对合规性、调度和检查准备的深刻理解反映了多年深思熟虑的执行。我们期待与团队紧密合作,强化运营,支持产品创新,并帮助公司在长期内负责任地扩展业务。”

“Joining Exa Capital represents an exciting next chapter for StaffReady,” said John Janzen, Founder and CTO at StaffReady…

“加入Exa Capital代表着StaffReady令人兴奋的下一章,”StaffReady创始人兼首席技术官约翰·詹森表示……

Full release here

完整发布在这里

, originally announced February 16th, 2026.

,最初宣布于2026年2月16日。

Tags

标签

Danaher Corporation

丹纳赫公司

EXA Capital

EXA资本

Health IT Acquisitions

健康信息技术采购

Healthcare M&A

医疗保健并购

John Janzen

约翰·詹森

Julie Sawyer Montgomery

朱莉·索耶·蒙哥马利

Masimo Corporation

马西莫公司

Mike Knebel

迈克·内贝尔

Rainer M. Blair

赖纳·M·布莱尔

StaffReady

员工就绪

Get Fresh Healthcare & IT Stories Delivered Daily

获取最新的医疗保健和IT故事每日送达

Join thousands of your healthcare & HealthIT peers who subscribe to our daily newsletter.

加入成千上万订阅我们每日新闻的医疗保健和健康信息技术同行行列。

We respect your privacy and will never sell or give out your contact information

我们尊重您的隐私,绝不会出售或泄露您的联系信息。